Product
OHB-607
1 clinical trial
4 indications
Indication
Bronchopulmonary DysplasiaIndication
Chronic Lung Disease of PrematurityIndication
Intraventricular HemorrhageIndication
Retinopathy of PrematurityClinical trial
A Phase 2b, Multicenter, Randomized, Open-label, Two-Arm Study to Evaluate the Clinical Efficacy and Safety of OHB-607 in Preventing Chronic Lung Disease in Extremely Premature Infants Compared to Standard Neonatal CareStatus: Active (not recruiting), Estimated PCD: 2026-08-28